Haibing Guo

Discovery of a ZIP7 inhibitor from a Notch pathway screen

Amy Y. Chen, Stephen M. Canham, John A. Tallarico, 2019, Nature Chemical Biology.

An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases

D. Ju, Haibing Guo, S. Deng, 2020, Frontiers in Immunology.

Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.

M. P. Dillon, P. Atadja, Youzhen Wang, 2017, Journal of medicinal chemistry.

Resting State fMRI and Improved Deep Learning Algorithm for Earlier Detection of Alzheimer’s Disease

Yongjin Zhang, Haibing Guo, Haibing Guo, 2020, IEEE Access.

A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques

J. Min, Xueyi Huang, Yiwu Zhou, 2021, bioRxiv.

A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351

J. Min, Yiwu Zhou, W. Guan, 2021, mAbs.